CROíVALVE
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
CROíVALVE
Industry:
Medical Device
Founded:
2016-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.croivalve.com
Total Employee:
1+
Status:
Active
Total Funding:
17.18 M USD
Technology used in webpage:
Microsoft Exchange Online Organization Schema Facebook Sharer Pinterest
Similar Organizations
GuRu
Enables safe, effective and customizable transmission of power over-the-air using proprietary mmWave and Smart RF Lensing technology
Ava
Ava is a patented multi-sensor bracelet, which allows women to precisely and conveniently predict fertile days.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Health2Sync
Health2Sync develops systems that transform smartphones into legacy medical devices and smart health monitoring machines.
OxSonics Therapeutics
OxSonics® Therapeutics’ proprietary drug delivery platform technology, SonoTran®
Unchained Labs
Unchained Labs is a developer of life science biologics tools designed to help researchers break free from tools that just don't cut it.
Current Employees Featured
Founder
Investors List
Broadview Ventures
Broadview Ventures investment in Series A - CroíValve
Elkstone Capital Partners
Elkstone Capital Partners investment in Series A - CroíValve
Halo Business Angel Network
Halo Business Angel Network investment in Series A - CroíValve
Dublin Business Innovation Centre
Dublin Business Innovation Centre investment in Series A - CroíValve
Atlantic Bridge University Fund
Atlantic Bridge University Fund investment in Series A - CroíValve
Enterprise Ireland
Enterprise Ireland investment in Series A - CroíValve
Irrus Investments
Irrus Investments investment in Series A - CroíValve
SOSV
SOSV investment in Series A - CroíValve
Ascentifi
Ascentifi investment in Series A - CroíValve
HBAN Medtech Syndicate
HBAN Medtech Syndicate investment in Seed Round - CroíValve
Official Site Inspections
http://www.croivalve.com Semrush global rank: 9.55 M Semrush visits lastest month: 141
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "CroíValve"
Team - CroíValve
Team CroíValve is an early stage medical device company focused on developing a minimally invasive device for the treatment of tricuspid regurgitation.See details»
CroíValve - Crunchbase Company Profile & Funding
Medical Product Outsourcing — MedTech & Irrus Syndicates Lead Study Funding for CroiValve's Transcatheter Tricuspid Device News • Aug 8, 2024 Silicon …See details»
CroiValve Company Profile 2024: Valuation, Funding & Investors
CroiValve General Information Description. Developer of a minimally invasive surgical device designed to treat severe tricuspid regurgitation. The company's device can be delivered …See details»
CroiValve Company Profile - MedTech Innovator
CroiValve intends to provide them with one, resulting in benefits to patients, physicians, and our healthcare systems: ... MedTech Innovator is a 501(c)(3) nonprofit organization and the largest …See details»
CroiValve Ltd - VentureRadar
Similar Companies: TRICARES GMBH Germany Privately Held TRiCares is a medical device company specializing in minimally invasive solutions for the treatment of tricuspid regurgitation …See details»
CroíValve - Funding, Financials, Valuation & Investors - Crunchbase
CroíValve is a developed safe, effective, easy to use, percutaneous solution company.See details»
CroíValve - Overview, News & Similar companies | ZoomInfo.com
CroíValve contact info: Phone number: +353 12552139 Website: www.croivalve.com What does CroíValve do? CroíValve was founded in 2016 and is a spin-out from EIT Health partner Trinity …See details»
CroiValve - Company Profile - Tracxn
Nov 13, 2024 CroiValve ranks 17th among 107 active competitors. 50 of its competitors are funded while 27 have exited. Overall, CroiValve and its competitors have raised over $3.32B in …See details»
CroiValve | Dublin, Ireland Startup
Led by an experienced team, CroíValve is developing a transcatheter device to treat Tricuspid Regurgitation; a progressive, debilitating disease affecting 550,000 patients annually. This is a …See details»
CroiValve Company Profile - Office Locations, Competitors ... - Craft
CroiValve is a medical device company developing a transcatheter device to treat defective heart valves. The Company's device is delivered through the heart’s blood vessels and seals the …See details»
CroíValve raises $16m in Series B for heart valve treatment device
The funding will finance an early feasibility study of its flagship product Duo to evaluate its safety and performance in treating tricuspid regurgitation. CroíValve, a medtech start-up that spun …See details»
CroíValve secures $16M to advance heart valve treatment
Aug 15, 2024 EIT Health-supported start-up, CroíValve, has successfully closed a $16 million Series B funding round to further develop its innovative heart valve treatment technology.. …See details»
CEO - CroíValve
Dr Lucy O'Keeffe: CEO Lucy has extensive experience leading medical device development programs. She worked as a cross-functional lead at Medtronic, managing R&D programs from …See details»
Croivalve - SOSV
Jan 26, 2024 CroíValve is developing a transcatheter device to treat Tricuspid Regurgitation, a common heart valve disorder for which there are no commercially-available, minimally …See details»
S1E1 - CroiValve Takes on the (No Longer) Forgotten Valve
Introduction. Meet Lucy O’Keeffe, PhD.Lucy is CEO of CroíValve (pronounced cree-valve after the Gaelic word for heart), a Dublin-based start-up focusing on the repair of the no-longer …See details»
CroiValve Company Information - Funding, Investors, and More
The company CroiValve has raised a total of $16m in funding over 1 rounds. Key Insights: Series B: $16m; 2024. CroiValve Series B (2024, $16M) $16m. Discover Iwoca. Company size. 11 - …See details»
CROIVALVE LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CROIVALVE LIMITED of DUBLIN 1. Get the latest business insights from Dun & Bradstreet.See details»
CroíValve Raises an €8M Series A Round to Support a Feasibility ...
Feb 4, 2022 CroíValve, a Dublin based medical device company developing a novel treatment for tricuspid regurgitation, has raised a Series A round to fund a Feasibility clinical study with …See details»
Technology - CroíValve
Technology CroíValve DUO Tricuspid Coaptation Valve system is a novel approach that combines repair and replacement to provide the right solution for the right heart.See details»